Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer

The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells

We haven't written up this one. Scientific American has the full story — the link below goes straight to it.

Read the original at scientificamerican.com →

More in Health & Medicine

More from Wednesday 19 August →